
Pudugrammam Krishna Iyer Vaidyanathan
About Pudugrammam Krishna Iyer Vaidyanathan
Data last updated:
Pudugrammam Krishna Iyer Vaidyanathan is a Director at Rhine Biogenics Private Limited (since 2003), Director at Rineus Health Care Company Private Limited (since 2013) and Director at Renolife Pharma (India) Private Limited (since 2010), and holds 4 more current directorships. The companies operate in Pharma, Healthcare and Chemicals. The 6 current companies with reported revenue have a combined latest revenue of ₹79.04 Cr; the largest is Rhine Biogenics Private Limited at ₹53.20 Cr (FY 2025). Earlier, Pudugrammam Krishna Iyer Vaidyanathan was a Director at Maya Biotech Private Limited (2016–2018) and Director at Rhine Formulations Private Limited (2015–2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 Oct 2003 | 2003 | ₹53.20 Cr (FY 2025) | Active | |
| Director | 05 Mar 2013 | 2012 | ₹8.76 Cr (FY 2025) | Active | |
| Director | 11 Jun 2010 | 2008 | ₹7.51 Cr (FY 2024) | Active | |
| Director | 08 Jun 2006 | 2006 | ₹5.14 Cr (FY 2025) | Active | |
| Director | 22 Feb 2019 | 2019 | ₹4.42 Cr (FY 2025) | Active | |
| Director | 10 Jan 2019 | 2019 | ₹27,804 (FY 2024) | Active | |
| Partner | 10 Apr 2018 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Feb 2016 | 1998 | ₹42.50 Cr (FY 2024) | Active | |
| Director | 15 Apr 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Pudugrammam Krishna Iyer Vaidyanathan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pudugrammam Krishna Iyer Vaidyanathan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pudugrammam Krishna Iyer Vaidyanathan
Pudugrammam Krishna Iyer Vaidyanathan currently holds 7 directorships: Rhine Biogenics Private Limited (Director, since 08 Oct 2003, revenue ₹53.20 Cr (FY 2025)); Rineus Health Care Company Private Limited (Director, since 05 Mar 2013, revenue ₹8.76 Cr (FY 2025)); Renolife Pharma (India) Private Limited (Director, since 11 Jun 2010, revenue ₹7.51 Cr (FY 2024)); Rhine Life Sciences Private Limited (Director, since 08 Jun 2006, revenue ₹5.14 Cr (FY 2025)); R-Vision Eye Hospital Private Limited (Director, since 22 Feb 2019, revenue ₹4.42 Cr (FY 2025)); and 2 more.
Pudugrammam Krishna Iyer Vaidyanathan was first appointed on 08 Oct 2003 as Director at Rhine Biogenics Private Limited. The most recent appointment on record is 22 Feb 2019 at R-Vision Eye Hospital Private Limited.
The 6 current companies of Pudugrammam Krishna Iyer Vaidyanathan that report revenue have a combined latest revenue of ₹79.04 Cr: Rhine Biogenics Private Limited ₹53.20 Cr (FY 2025); Rineus Health Care Company Private Limited ₹8.76 Cr (FY 2025); Renolife Pharma (India) Private Limited ₹7.51 Cr (FY 2024); Rhine Life Sciences Private Limited ₹5.14 Cr (FY 2025); R-Vision Eye Hospital Private Limited ₹4.42 Cr (FY 2025); and 1 more.
Pudugrammam Krishna Iyer Vaidyanathan held 2 earlier board appointments: Maya Biotech Private Limited (Director, 09 Feb 2016 to 01 Nov 2018); Rhine Formulations Private Limited (Director, 15 Apr 2015 to 31 Jan 2018).
The current boards of Pudugrammam Krishna Iyer Vaidyanathan's companies include Ajith Sukumaran Nair (Rhine Biogenics Private Limited), Ajitkumar Warrior (Rhine Biogenics Private Limited), Jayakumar Narayanan Nair (Rhine Biogenics Private Limited), Kallungal Unni Jothish (Rhine Biogenics Private Limited), Madathiveetil Ramesh (Rhine Biogenics Private Limited), Peter Jose Ansal Parriathcherry (Rhine Biogenics Private Limited), among others.